Related Experiment Video
Updated: Feb 12, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
Galectins Control mTOR in Response to Endomembrane Damage
Jingyue Jia1, Yakubu Princely Abudu2, Aurore Claude-Taupin1
1Autophagy Inflammation and Metabolism Center of Biomedical Research Excellence, University of New Mexico Health Sciences Center, 915 Camino de Salud, NE, Albuquerque, NM 87131, USA; Department of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center, 915 Camino de Salud, NE, Albuquerque, NM 87131, USA.
Abstract:
The Ser/Thr protein kinase mTOR controls metabolic pathways, including the catabolic process of autophagy. Autophagy plays additional, catabolism-independent roles in homeostasis of cytoplasmic endomembranes and whole organelles. How signals from endomembrane damage are transmitted to mTOR to orchestrate autophagic responses is not known. Here we show that mTOR is inhibited by lysosomal damage. Lysosomal damage, recognized by galectins, leads to association of galectin-8 (Gal8) with the mTOR apparatus on the lysosome. Gal8 inhibits mTOR activity through its Ragulator-Rag signaling machinery, whereas galectin-9 activates AMPK in response to lysosomal injury. Both systems converge upon downstream effectors including autophagy and defense against Mycobacterium tuberculosis. Thus, a novel galectin-based signal-transduction system, termed here GALTOR, intersects with the known regulators of mTOR on the lysosome and controls them in response to lysosomal damage. VIDEO ABSTRACT.
Insights
Lysosomal damage inhibits the mTOR pathway via galectin-8 (Gal8), activating autophagy and defense mechanisms. This discovery reveals a new galectin-based signaling system (GALTOR) that regulates mTOR in response to cellular injury.
Area of Science:
- Cellular Biology
- Molecular Signaling
- Immunology
Background:
- The mechanistic target of rapamycin (mTOR) kinase regulates metabolic pathways, including autophagy.
- Autophagy is crucial for maintaining cellular and organelle homeostasis, beyond its catabolic roles.
- The signaling mechanisms linking endomembrane damage to mTOR-mediated autophagic responses remain unclear.
Purpose of the Study:
- To investigate how lysosomal damage signals are transmitted to mTOR to regulate autophagy.
- To identify the molecular players involved in sensing lysosomal damage and initiating cellular responses.
Main Methods:
- Investigated the role of galectins in sensing lysosomal damage.
- Examined the association of galectins with the mTOR signaling complex on lysosomes.
- Analyzed the impact of lysosomal damage on mTOR activity, AMPK activation, and downstream effectors like autophagy.
Main Results:
- Lysosomal damage inhibits mTOR activity, mediated by the association of galectin-8 (Gal8) with the lysosomal mTOR apparatus.
- Galectin-8 inhibits mTOR via the Ragulator-Rag signaling pathway.
- Galectin-9 activates AMP-activated protein kinase (AMPK) in response to lysosomal injury, converging with mTOR pathways on autophagy and defense against Mycobacterium tuberculosis.
Conclusions:
- A novel galectin-based signal-transduction system, termed GALTOR, has been identified.
- GALTOR intersects with known mTOR regulators at the lysosome, controlling cellular responses to damage.
- This pathway is critical for orchestrating autophagy and immune defense following lysosomal injury.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Control System Problem
When forming a closed-loop system, issues can arise if the poles cross into the unstable region, leading to potential...
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...

